Sushela Chaidarun

Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial

Ofri Mosenzon, Thalia Marie Blicher, Signe Rosenlund et al. · The Lancet Diabetes & Endocrinology · 2019 · 317 citations · Full text

Diabetes Management, Urology, Medicine +11

Expression of epidermal growth factor (EGF), its receptor, and related oncoprotein (erbB-2) in human pituitary tumors and response to EGF in vitro.

Sushela Chaidarun, Margaret C. Eggo, Michael C. Sheppard et al. · Endocrinology · 1994 · 75 citations

Normal Pituitary Cells, Epidermal Growth Factor, Hormone-secreting Tumors +15

Differential Expression of Estrogen Receptor-β (ERβ) in Human Pituitary Tumors: Functional Interactions with ERα and a Tumor-Specific Splice Variant1

Sushela Chaidarun, Brooke Swearingen, Joseph M. Alexander · The Journal of Clinical Endocrinology & Metabolism · 1998 · 62 citations · Full text

A Tumor-Specific Truncated Estrogen Receptor Splice Variant Enhances Estrogen-Stimulated Gene Expression

Sushela Chaidarun, Joseph M. Alexander · Molecular Endocrinology · 1998 · 52 citations · Full text

Tumor-Specific Expression of Alternatively Spliced Estrogen Receptor Messenger Ribonucleic Acid Variants in Human Pituitary Adenomas¹

Sushela Chaidarun, Anne Klibanski, Joseph M. Alexander · The Journal of Clinical Endocrinology & Metabolism · 1997 · 50 citations